DiaMedica Therapeutics, Inc.
DiaMedica-Logo
Navigate DiaMedica Therapeutics, Inc.
Home
About Us
Company Overview
Leadership Team
Board of Directors
Clinical Advisory Boards
Science
Our Science
Pipeline
Diseases We Target
Overview
IgA Nephropathy
African Americans - Hypertensive with CKD
Acute Ischemic Stroke
Investors & Media
Investors Home
Press Releases
Events & Presentations
Nasdaq Stock Information
Analyst Coverage
Financial Reports
Governance
Investor Resources
Careers
Contact
Home
Investors & Media
Financial Reports
SEC Filings
SEC Filings
Filter Filings:
View All
10-K
10-Q
20FR12B
20FR12B/A
3
4
424B4
424B5
8-A12B
8-A12B/A
8-K
CERT
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
REGDEX
RW
S-1
S-1/A
S-3
S-8
SC 13G
SC 13G/A
UPLOAD
Date
Form
Description
Docs
XBRL
Pages
02/12/20
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
10
02/11/20
424B5
Prospectus filed pursuant to Rule 424(b)(5)
97
02/11/20
8-K
Current report filing
Related Documents
EX-99.1
EX-99.2
39
02/11/20
424B5
Prospectus filed pursuant to Rule 424(b)(5)
97
01/31/20
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
6
01/09/20
EFFECT
Notice of Effectiveness
1
01/07/20
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
1
01/06/20
UPLOAD
SEC-generated letter
Related Documents
TEXT-EXTRACT
1
01/03/20
8-K
Current report filing
Related Documents
EX-10.1
19
01/02/20
S-3
Registration statement for specified transactions by certain issuers
Related Documents
EX-5.1
EX-5.2
EX-23.1
39
<< Previous
1
2
3
4
5
6
7
8
9
10
...13
Next >>